A political history of medicare and prescription drug coverage

The Milbank Quarterly
Thomas R OliverHelene L Lipton

Abstract

This article examines the history of efforts to add prescription drug coverage to the Medicare program. It identifies several important patterns in policymaking over four decades. First, prescription drug coverage has usually been tied to the fate of broader proposals for Medicare reform. Second, action has been hampered by divided government, federal budget deficits, and ideological conflict between those seeking to expand the traditional Medicare program and those preferring a greater role for private health care companies. Third, the provisions of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 reflect earlier missed opportunities. Policymakers concluded from past episodes that participation in the new program should be voluntary, with Medicare beneficiaries and taxpayers sharing the costs. They ignored lessons from past episodes, however, about the need to match expanded benefits with adequate mechanisms for cost containment. Based on several new circumstances in 2003, the article demonstrates why there was a historic opportunity to add a Medicare prescription drug benefit and identify challenges to implementing an effective policy.

References

Jan 1, 1992·Journal of Neural Transmission. Parkinson's Disease and Dementia Section·P GoodwinM S Starr
Jan 1, 1990·Health Affairs·T RiceJ Gabel
Apr 1, 1997·Journal of Health Politics, Policy and Law·J S Hacker, T Skocpol
Aug 1, 1997·Journal of Health Politics, Policy and Law·M A Peterson
Jun 17, 1998·Journal of Health Politics, Policy and Law·L Etheredge
Feb 2, 1999·Health Affairs·B C Vladeck
May 13, 1999·The New England Journal of Medicine·B C Vladeck
Jun 3, 1999·Annual Review of Public Health·H L LiptonK C Hertz
Jul 30, 1999·Health Affairs·J Rother
Mar 16, 2000·Health Affairs·H L LiptonL H Syed
Apr 22, 2003·Health Affairs·Mary A LaschoberAllison A Strabic
Jan 31, 2004·Annals of the New York Academy of Sciences·A GrajkowskiS L Beaucage
Mar 9, 2004·Health Affairs·Katharine LevitUNKNOWN Health Accounts Team
Oct 28, 2004·Health Affairs·Jonathan Oberlander

❮ Previous
Next ❯

Citations

Apr 14, 2012·Journal of Aging & Social Policy·Joshua M Wiener
Aug 29, 2006·Academic Medicine : Journal of the Association of American Medical Colleges·Stanley K Frencher, Sherry Glied
Jan 12, 2010·Annual Review of Medicine·Gretchen Jacobson, Gerard Anderson
Mar 15, 2006·Annual Review of Public Health·Thomas R Oliver
Aug 7, 2014·Journal of Pharmaceutical Policy and Practice·Arthur Daemmrich, Ansuman Mohanty
Jul 30, 2014·Hand Clinics·Joshua M Adkinson, Kevin C Chung
Jul 23, 2013·Journal of Public Economics·Margaret E Blume-Kohout, Neeraj Sood
Sep 15, 2006·Mayo Clinic Proceedings·Alex D FedermanWilliam H Shrank
Mar 25, 2005·The Milbank Quarterly·Vittorio MaioDavid Chess
Mar 7, 2012·Pharmacotherapy·J Russell Teagarden, Eric J Stanek
Jan 31, 2006·American Journal of Surgery·Michael E DeBakey
Apr 6, 2005·The American Journal of Medicine·James E Dalen, Douglas J Hartz
Aug 3, 2016·Health Services Research·Young Joo Park, Erika G Martin
Mar 2, 2018·Orthopedics·Adam E M EltoraiAlan H Daniels
Oct 7, 2015·Health Affairs·John F HoadleyPatricia Neuman
Nov 12, 2016·Journal of the American Heart Association·Steven A Farmer, William B Borden
Jan 24, 2008·Clinical Orthopaedics and Related Research·Dan MatlockAnne Epstein
Sep 26, 2008·Medical Care·Sidney J Socolar
Feb 26, 2019·The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association·Timothy CallaghanJane Bolin
Feb 6, 2019·Journal of Neurosurgery·Jack M HaglinNaresh P Patel
Mar 29, 2019·Annals of Surgery·Jack M HaglinAlan H Daniels
May 29, 2019·Annual Review of Pharmacology and Toxicology·Michelle M Mello
Jun 27, 2020·Plastic and Reconstructive Surgery·Nikita GuptaWilliam J Casey
Mar 29, 2012·Clinical Pharmacology and Therapeutics·J R TeagardenL Nichols
Sep 19, 2020·Journal of Orthopaedic Trauma·Jack M HaglinKenneth A Egol
Mar 10, 2021·International Journal of Health Services : Planning, Administration, Evaluation·Marc A Rodwin
Apr 9, 2021·Journal of Clinical Pharmacy and Therapeutics·Justine AlderferT Joseph Mattingly
Apr 10, 2021·Plastic and Reconstructive Surgery·Charalampos SiotosAmir H Dorafshar
Apr 27, 2021·Annals of Vascular Surgery·Jack M HaglinAndrew J Meltzer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
Drew E Altman
Health Affairs
Katharine LevitHealth Accounts Team
JAMA : the Journal of the American Medical Association
E Ginzberg
© 2022 Meta ULC. All rights reserved